Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas

• Leandro Cerchietti ,

  * E-mail: wilhelm.woessmann@paediat.med.uni-giessen.de (WW); lec2010@med.cornell.edu (LC)

  Affiliations Hematology and Oncology Division, Weill Cornell Medical College, Cornell University, New York, New York, United States of America, Pharmacology Department, Weill Cornell Medical College, Cornell University, New York, New York, United States of America

  ⨯
• Christine Damm-Welk,

  Affiliation Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany

  ⨯
• Inga Vater,

  Affiliation Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Wolfram Klapper,

  Affiliation Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Lana Harder,

  Affiliation Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Christiane Pott,

  Affiliation 2nd Medicine Department, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Shao Ning Yang,

  Affiliations Hematology and Oncology Division, Weill Cornell Medical College, Cornell University, New York, New York, United States of America, Pharmacology Department, Weill Cornell Medical College, Cornell University, New York, New York, United States of America

  ⨯
• Alfred Reiter,

  Affiliation Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany

  ⨯
• Reiner Siebert,

  Affiliation Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  ⨯
• Ari Melnick,

  Affiliations Hematology and Oncology Division, Weill Cornell Medical College, Cornell University, New York, New York, United States of America, Pharmacology Department, Weill Cornell Medical College, Cornell University, New York, New York, United States of America

  ⨯
• Willi Woessmann

  * E-mail: wilhelm.woessmann@paediat.med.uni-giessen.de (WW); lec2010@med.cornell.edu (LC)

  Affiliation Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany

  ⨯